ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1934

Knee Symptom Phenotyping Incorporating Pain and Function: A Multiple-Trajectory Modeling-Based Study Using Data from the Osteoarthritis Initiative (OAI)

Yong Ge1, Thang Doung2, Shen Liu3, Xiaoxiao Sun4, Tuhina Neogi5, Amanda Nelson6, Jeffery Duryea7 and Kent Kwoh8, 1Department of Information Sciences, Eller College of Manangement, University of Arizona, Tucson, AZ, 2Department of Computer Science, University of Arizona College of Science, Tucson, AZ, 3Department of Biostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, 4Department of Biostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, 5Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 6University of North Carolina at Chapel Hill, Chapel Hill, NC, 7Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 8University of Arizona, Tucson, AZ

Meeting: ACR Convergence 2024

Keywords: functional status, Osteoarthritis, Outcome measures, pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Health Services Research – ACR/ARP Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Knee pain is the most common presenting symptom of knee OA, and functional limitations are a common sequelae. Understanding the various patterns of pain and function changes over time can help identify individuals most in needed of targeted interventions. Prior studies have typically assessed only knee pain with a single, one-knee pain measure and have not incorporated function in a holistic approach to more comprehensively understanding symptom patterns. Our objective was to analyze knee symptoms (i.e., pain/function) data over 96 months among individuals with or at risk for knee OA from the OAI and identify representative temporal knee pain/function phenotypes based on four different knee pain/function measurements.

Methods: We used the following knee pain/function measures from each OAI time-point from baseline to month 96 to develop our knee symptom phenotypes: WOMAC function score (0-68, none to extreme functional limitation), WOMAC pain score (0-20, none to extreme pain), KOOS knee pain frequency (0-4, i.e., none, monthly, weekly, daily), and the Numerical Rating Scale (NRS) for knee pain severity (0-10, none to worst pain). To select the knees for inclusion, we separately identified knees with a score of 0 at baseline for each particular pain/function measure; these were each considered to be a ‘filter’.  Within each set of selected knees based on an individual filter, we employed group-based multiple-trajectory modeling (GBMTM) to cluster the selected knees into distinct knee pain/function progression trajectories. In addition, we created a “zero-on-all at baseline” filter to select those knees that had a score of 0 for all four measures at baseline and applied GBMTM to this subset of knees.

Results: The numbers of selected knees by each measure that had a score of 0 at baseline were 2,156 for WOMAC function, 2,560 for WOMAC pain, 1,552 for KOOS knee pain frequency, 1,994 for NRS, and 1,136 for the “zero-on-all at baseline” filter. Three distinct clusters were generated by GBMTM with the knees selected by each of the four single measure-based selection criteria (Figure 1). For example, for the WOMAC function set, the knees in the blue cluster accounted for 17.8% of the selected knees with a score of 0 at baseline. This cluster showed rapid progression over follow-up across all four measures. In contrast, the knees in the green (39.1%) cluster demonstrated slow progression, and knees in the red (43.1%) cluster demonstrated very little progression. Similar patterns can be observed when the other three filters were applied. Figure 2 illustrates the results of the knees selected with the “zero-on-all at baseline” filter. The progression patterns for the three clusters were similar to those shown in Figure 1.

Conclusion: Based on four pain/function measures in OAI, we identified three distinct temporal phenotypes of knee pain/function progression patterns, which resulted in similar trajectories regardless of the pain/function measure. These patterns were similar for each of the four pain/function study samples and the “zero-on-all at baseline” sample. The cluster with rapid symptom progression may represent a group to target with interventions earlier in their disease course.

Supporting image 1

The average trajectory (solid line) is shown; dashed lines represent the confidence intervals. Each column shows the multi-trajectory simultaneous results for each of the four symptom measures based on the specific measure used to select the sample. Each row shows the specific knee symptom results for each of the four different filters.

Supporting image 2

The average trajectory (solid line) is shown; dashed lines represent the confidence intervals.


Disclosures: Y. Ge: None; T. Doung: None; S. Liu: None; X. Sun: None; T. Neogi: Amgen, 2, Eli Lilly, 2, GlaxoSmithKlein(GSK), 2, Novartis, 2, Sobi, 2; A. Nelson: MedScape Education, 6, NestleHealth, 6; J. Duryea: None; K. Kwoh: Cumberland, 5, Express Scripts, 2, Kiniska, 5, Kolon Tissue Gene, 12, Independent Data Monitoring Committee, Mindera, 5.

To cite this abstract in AMA style:

Ge Y, Doung T, Liu S, Sun X, Neogi T, Nelson A, Duryea J, Kwoh K. Knee Symptom Phenotyping Incorporating Pain and Function: A Multiple-Trajectory Modeling-Based Study Using Data from the Osteoarthritis Initiative (OAI) [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/knee-symptom-phenotyping-incorporating-pain-and-function-a-multiple-trajectory-modeling-based-study-using-data-from-the-osteoarthritis-initiative-oai/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/knee-symptom-phenotyping-incorporating-pain-and-function-a-multiple-trajectory-modeling-based-study-using-data-from-the-osteoarthritis-initiative-oai/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology